Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Taylor

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nature Medicine|March 11, 2025
The Rare Therapies Launchpad: a pilot program for individualized medicines in the UKDaniel J O'Connor, Parker Moss, Matthew Wood, et al.
Circulation|October 6, 2010
Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathyKhalid Abozguia, Perry Elliott, William McKenna, et al.
Nature Genetics|May 8, 2012
Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1Emma Jaeger, Simon Leedham, Annabelle Lewis, et al.
Communications Biology|April 22, 2020
Multi-level evidence of an allelic hierarchy of USH2A variants in hearing, auditory processing and speech/language outcomesPeter A Perrino, Lidiya Talbot, Rose Kirkland, et al.
Nature Genetics|September 18, 2007
A genome-wide association study of global gene expressionAnna L Dixon, Liming Liang, Miriam F Moffatt, et al.
Human Molecular Genetics|March 27, 2013
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancerDavid N Church, Sarah E W Briggs, Claire Palles, et al.
Blood|August 24, 2012
Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patternsAnna Schuh, Jennifer Becq, Sean Humphray, et al.
Gut|March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMSDan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 13, 2019
PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristicsAllan Bayat, Alexej Knaus, Annika Wollenberg Juul, et al.
Blood|August 29, 2015
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLLRomain Guièze, Pauline Robbe, Ruth Clifford, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nature Medicine|March 11, 2025
The Rare Therapies Launchpad: a pilot program for individualized medicines in the UKDaniel J O'Connor, Parker Moss, Matthew Wood, et al.
Circulation|October 6, 2010
Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathyKhalid Abozguia, Perry Elliott, William McKenna, et al.
Nature Genetics|May 8, 2012
Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1Emma Jaeger, Simon Leedham, Annabelle Lewis, et al.
Communications Biology|April 22, 2020
Multi-level evidence of an allelic hierarchy of USH2A variants in hearing, auditory processing and speech/language outcomesPeter A Perrino, Lidiya Talbot, Rose Kirkland, et al.
Nature Genetics|September 18, 2007
A genome-wide association study of global gene expressionAnna L Dixon, Liming Liang, Miriam F Moffatt, et al.
Human Molecular Genetics|March 27, 2013
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancerDavid N Church, Sarah E W Briggs, Claire Palles, et al.
Blood|August 24, 2012
Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patternsAnna Schuh, Jennifer Becq, Sean Humphray, et al.
Gut|March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMSDan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 13, 2019
PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristicsAllan Bayat, Alexej Knaus, Annika Wollenberg Juul, et al.
Blood|August 29, 2015
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLLRomain Guièze, Pauline Robbe, Ruth Clifford, et al.
Pageof 3